PUNE: A total of 17 mutations in the genetic make-up of the SARS-CoV-2 virus must be detected before experts can confirm that the new variant originated in the UK.
Scientists who have been performing genome sequencing at the Pune-based Medical Research Council of India at the Pune-National Institute of Virology, said PIV is a level four biosafety laboratory (BSL-4) first laboratory to separate the variant and culture Saturday from the sample of a British Covid-positive practitioner.
“We need to find all 17 mutations to prove it is UK snoring. To do that, we need to map the whole genome of the virus and not just the spike gene. The UK variant has several mutations in different genes, “said scientist Varsha Potdar, head of the NIV National Flu Center.
A fixed number of clinical samples, which tested positive for Covid via RT-PCR, are now being sent to NIV for whole genome sequencing.
NIV managing director Sarah Cherian said, “It is too early to say how the pressure will play out in our population. But as it is a cause for concern, an improved molecular study is definitely needed. “.
When asked if it was possible to develop a test to detect new mutations, Cherian said, “Because mutations in the UK species are in multiple genes, simply mapping the entire genome is a must. find out the strain type “.
Scientists who have been performing genome sequencing at the Pune-based Medical Research Council of India at the Pune-National Institute of Virology, said PIV is a level four biosafety laboratory (BSL-4) first laboratory to separate the variant and culture Saturday from the sample of a British Covid-positive practitioner.
“We need to find all 17 mutations to prove it is UK snoring. To do that, we need to map the whole genome of the virus and not just the spike gene. The UK variant has several mutations in different genes, “said scientist Varsha Potdar, head of the NIV National Flu Center.
A fixed number of clinical samples, which tested positive for Covid via RT-PCR, are now being sent to NIV for whole genome sequencing.
NIV managing director Sarah Cherian said, “It is too early to say how the pressure will play out in our population. But as it is a cause for concern, an improved molecular study is definitely needed. “.
When asked if it was possible to develop a test to detect new mutations, Cherian said, “Because mutations in the UK species are in multiple genes, simply mapping the entire genome is a must. find out the strain type “.